Related Experiment Video

Updated: Feb 19, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.7K

Risk Factors for Epilepsy Recurrence after Revascularization in Pediatric Patients with Moyamoya Disease

Yonggang Ma1, Meng Zhao1, Qian Zhang1

  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing; China National Clinical Research Center for Neurological Diseases, Beijing; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People's Republic of China.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|November 13, 2017
PubMed
Abstract

Insights

Epilepsy duration predicts seizure recurrence in pediatric moyamoya disease (MMD) patients after revascularization. Surgical bypass type did not significantly impact seizure prevention in these MMD cases.

Area of Science:

  • Neurology
  • Neurosurgery
  • Pediatric Neurology

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular disorder.
  • Epilepsy is a common complication in pediatric MMD patients.
  • Revascularization surgery is performed to prevent ischemic events.

Purpose of the Study:

  • To identify risk factors for seizure recurrence in pediatric MMD patients.
  • To evaluate the effectiveness of different surgical procedures for seizure control in pediatric MMD.

Main Methods:

  • Retrospective review of 696 MMD patients (2009-2015).
  • Identified 28 pediatric MMD patients with pre-operative seizures.
  • Analyzed seizure characteristics and recurrence predictors.

Main Results:

  • Seven out of 28 pediatric patients (25%) experienced recurrent seizures post-operatively.
  • Longer epilepsy duration was an independent predictor of seizure recurrence (OR 3.84, P=.035).
  • Direct and indirect bypass surgeries showed no significant difference in seizure prevention.

Conclusions:

  • Epilepsy duration is a significant risk factor for post-revascularization seizure recurrence in pediatric MMD.
  • Current surgical approaches for MMD do not differ in their efficacy for preventing seizures.
Keywords:
Moyamoya diseaseepilepsyoutcomespediatricrevascularization

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

21.2K
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

3.3K

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
391
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
962